The number of antibiotic-resistant strains continues to rise rapidly. Statistics from the Centers for Disease Control and Prevention (CDC) and the Infectious Diseases Society of America (IDSA) point to alarming trends that are...
It is with great excitement that we unveil our network-wide redesign. Please read further to learn more about a few of our new features, and browse around to explore the new site!
Patients with heart failure and reduced ejection fraction (HF-REF) treated with an investigational angiotensin receptor neprilysin Inhibitor (ARNI) are more likely to reduce cardiovascular death and heart failure hospitalization than...
Teens who received the collaborative care intervention in primary care had significantly greater improvements in depressive symptoms than teens who were receiving treatment as usual.

FDA APPROVALS
FDA approves secukinumab for ...

FDA has approved secukinumab (Cosentyx, Novartis) for the treatment of moderate-to-severe plaque psoriasis.

FDA approves renal therapy solution
FDA approves new obesity device
FDA approves Signifor LAR to treat ...

CLINICAL
Study assesses best treatments to ...

It is important to ensure established migraine medications are available for the patients who need them, according to a ...

FDA approves secukinumab for ...
Study evaluates use of novel oral ...
Drug adherence low for patients new ...

DRUGS IN PERSPECTIVE
Drugs in Perspective: Myalept ...

Myalept (metreleptin) is a leptin analogue with the same physiologic effects as leptin.11 Metreleptin was granted a ...

Drugs in Perspective: Otezla ...
Drugs in Perspective: Zykadia ...
Drugs in Perspective: Dalvance

Latest Tweets Follow